Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of the Effects of Apigenin, a Possible Therapeutic Agent, on Cytotoxic and SWH Pathway in Colorectal Cancer (HT29) Cells. | Adv Pharm Bull | 2023 | 36721804 | PubTator, text mining | PubMed |
| Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing. | Cell Regen | 2023 | 36720733 | PubTator, text mining | PubMed |
| Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2/PlexinA1. | Cell Signal | 2023 | 36720439 | PubTator, text mining | PubMed |
| Regulation of Photosensitivity by the Hippo Pathway in Lupus Skin. | Arthritis Rheumatol | 2023 | 36704840 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. | Cell Death Discov | 2023 | 36693834 | PubTator, text mining | PubMed |
| Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism. | Bioeng Transl Med | 2023 | 36684109 | PubTator, text mining | PubMed |
| Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 36684056 | PubTator, text mining | PubMed |
| Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. | World J Gastroenterol | 2023 | 36683709 | PubTator, text mining | PubMed |
| Identifying and Analyzing Topic Clusters in a Nutri-, Food-, and Diet-Proteomic Corpus Using Machine Reading. | Nutrients | 2023 | 36678141 | PubTator, text mining | PubMed |
| Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. | Int J Mol Sci | 2023 | 36674874 | PubTator, text mining | PubMed |
| Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | Int J Mol Sci | 2023 | 36674791 | PubTator, text mining | PubMed |
| A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules. | Chem Rev | 2023 | 36662637 | PubTator, text mining | PubMed |
| Transcriptional profiling of the developing rat ovary following intrauterine exposure to the endocrine disruptors diethylstilbestrol and ketoconazole. | Arch Toxicol | 2023 | 36653537 | PubTator, text mining | PubMed |
| Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity. | Cell Death Dis | 2023 | 36650140 | PubTator, text mining | PubMed |
| RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36643034 | PubTator, text mining | PubMed |
| Accentuated Hippo pathway and elevated miR-132 and miR-195a lead to changes of uteri and ovaries in offspring mice following prenatal exposure to vinclozolin. | Reprod Toxicol | 2023 | 36642194 | PubTator, text mining | PubMed |
| Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression. | Cell Death Dis | 2023 | 36635265 | PubTator, text mining | PubMed |
| Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer. | Cell Mol Life Sci | 2023 | 36633714 | PubTator, text mining | PubMed |
| An atlas of substrate specificities for the human serine/threonine kinome. | Nature | 2023 | 36631611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=27